Inari Medical, Inc.

NARI

US45332Y1091

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
38.42 ^USD	+0.92%		-0.44%	-40.82%

Apr. 02	Inari Medical, Inc. Appoints Tim Benner as Senior Vice President of U.S. Sales	CI
Apr. 01	Inari Medical, Inc.(NasdaqGS:NARI) added to S&P 600 Health Care	CI

Inari Medical, Inc.(NasdaqGS:NARI) added to S&P Composite 1500

April 28, 2022 at 12:00 am EDT

Latest news about Inari Medical, Inc.

Inari Medical, Inc. Appoints Tim Benner as Senior Vice President of U.S. Sales	Apr. 02	CI
Inari Medical, Inc.(NasdaqGS:NARI) added to S&P 600 Health Care	Mar. 31	CI
Inari Medical, Inc.(NasdaqGS:NARI) added to S&P 600	Mar. 31	CI
Inari Medical, Inc.(NasdaqGS:NARI) dropped from S&P 400 Health Care	Mar. 31	CI
Inari Medical, Inc.(NasdaqGS:NARI) dropped from S&P 400	Mar. 31	CI
Sector Update: Financial Stocks Gain Late Afternoon	Mar. 26	MT
Sector Update: Financial Stocks Rise Tuesday Afternoon	Mar. 26	MT
AppFolio to Join S&P MidCap 400, Inari Medical to Join S&P SmallCap 600; AppFolio Shares Rise	Mar. 26	MT
Sector Update: Tech Stocks Mixed Premarket Tuesday	Mar. 26	MT
Sector Update: Tech	Mar. 26	MT
AppFolio to Join S&P MidCap 400, Inari Medical to Join S&P SmallCap 600	Mar. 26	MT
Truist Securities Cuts Inari Medical's Price Target to $52 From $61, Reiterates Hold Rating	Mar. 22	MT
Inari Medical Insider Sold Shares Worth $251,461, According to a Recent SEC Filing	Mar. 14	MT
Inari Medical Announces Interim Two-Year Results from the ClotTriever CLOUT Registry	Mar. 12	CI
Top Premarket Decliners	Feb. 29	MT
Piper Sandler Downgrades Inari Medical to Neutral From Overweight, Cuts Price Target to $55 From $85	Feb. 29	MT
Morgan Stanley Lowers Price Target on Inari Medical to $75 From $83, Keeps Overweight Rating	Feb. 29	MT
Inari Medical Q4 Loss Narrows as Sales Increase -- Shares Decline Premarket	Feb. 29	MT
Transcript : Inari Medical, Inc., Q4 2023 Earnings Call, Feb 28, 2024	Feb. 28
Earnings Flash (NARI) INARI MEDICAL Reports Q4 Revenue $132.1M, vs. Street Est of $132.1M	Feb. 28	MT
Inari Medical, Inc. Provides Revenue Guidance for the Full Year 2024	Feb. 28	CI
Inari Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
Inari Medical, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 28	CI
Inari Medical, Inc. Announces Resignation of Kirk Nielsen from the Board Effective April 24, 2024	Feb. 23	CI
Needham Initiates Inari Medical With Buy Rating, $72 PT; Notes 'Attractive' Valuation, Expects 'Rapid' Improvement in Margin, Earnings in 2025, Beyond	Jan. 23	MT

Inari Medical, Inc. is a medical device company. The Companyâs products primarily consist of ClotTriever and FlowTriever systems, which are catheter-based mechanical thrombectomy systems that are used for the treatment of the venous thromboembolism (VTE) deep vein thrombosis (DVT), and pulmonary embolism (PE). Its InThrill system is used for the removal of emboli and thrombi from the peripheral vasculature. The LimFlow system is indicated for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and are at risk of major amputation. It also offers RevCore thrombectomy catheter, which is a thrombectomy device for venous stent thrombosis, Triever 16 Curve catheter, which is used for venous thrombus removal, and ClotTriever Bold catheter, which is used for DVT and the removal of acute and chronic clots in the peripheral vasculature. Its ClotTriever XL, which is a catheter for efficient clot removal with minimal blood loss.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-04-29 - Q1 2024 Earnings Release

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Inari Medical, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

38.07 USD

Average target price

71.3 USD

Spread / Average Target

+87.29%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Equipment

	1st Jan change	Capi.
INARI MEDICAL, INC.	-40.82%	2.21B
SHOCKWAVE MEDICAL, INC.	+73.17%	12.34B
PENUMBRA, INC.	-18.74%	7.96B
MASIMO CORPORATION	+16.15%	7.16B
GETINGE AB	+4.81%	5.72B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+5.99%	5.03B
APT MEDICAL INC.	+27.07%	4.35B
ASAHI INTECC CO., LTD.	-21.67%	3.99B
SKAN GROUP AG	+1.49%	2.01B
SHENZHEN YHLO BIOTECH CO., LTD.	+5.07%	1.85B

Medical Equipment